Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo
2008
Using siRNA to Target ANT2 in Breast Cancer Cells
publication
Evidence: high
Author Information
Author(s): Jang Ji-Young, Choi Yun, Jeon Yoon-Kyung, Kim Chul-Woo
Primary Institution: Seoul National University College of Medicine
Hypothesis
Can silencing ANT2 in breast cancer cells induce apoptosis and inhibit tumor growth?
Conclusion
Silencing ANT2 using RNA interference effectively induces apoptosis and inhibits tumor growth in breast cancer models.
Supporting Evidence
- ANT2 shRNA treatment in breast cancer cells led to reduced cell growth and increased apoptosis.
- Cells treated with ANT2 shRNA showed significant ATP depletion.
- Transfection with ANT2 shRNA resulted in cell cycle arrest in the G1 phase.
- ANT2 shRNA induced a cytotoxic bystander effect in neighboring cells.
- ANT2 shRNA treatment increased levels of TNFα and TNF-receptor I in transfected cells.
- ANT2 shRNA effectively inhibited tumor growth in vivo in mouse models.
Takeaway
Scientists found that turning off a specific gene called ANT2 in breast cancer cells can make the cells die and stop growing.
Methodology
The study used a DNA vector-based RNA interference approach to inhibit ANT2 expression in breast cancer cell lines and evaluated its effects in vitro and in vivo.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website